BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

ORSINI SPECIALTY PHARMACY — Lobbying — Receipts Report

LD-2 disclosure · Registration

ORSINI SPECIALTY PHARMACY

via SIRONA STRATEGIES LLC

1st Quarter (Jan 1 - Mar 31) · 2024Posted Apr 22, 2024Filing document ↗LDA record ↗

Coverage · Registration filing — establishes the registrant/client relationship. No periodic income or expenses are reported at registration.

Client

Name: ORSINI SPECIALTY PHARMACY
Description: specialty pharmacy
Location: Illinois · United States of America

Registrant

Firm: SIRONA STRATEGIES LLC
Description: Health care consulting.
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Health Issues
S.2973 - Modernizing and Ensuring PBM Accountability Act
LobbyistsKRISTA DROBAC · CHRISTOPHER JOSEPH ADAMEC
Covered position (KRISTA DROBAC): Schedule C/Sr Advisor, Centers for Medicare/Medicaid Services; Legis. Asst., Sen. Durbin; Fellow, Sen. Stabenow

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.